British Pharmacological Society’s Drug Discovery of the Year 2018 Announced

News   Dec 15, 2017 | Original story from British Pharmacological Society

 
British Pharmacological Society’s Drug Discovery of the Year 2018 Announced
 
 
 

RELATED ARTICLES

Fragile X: Drug Strategy Could Alleviate Behavioral & Cellular Deficiencies

News

Research in mice shows that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders.

READ MORE

Testosterone Effective at Combating Cachexia in Cancer Patients

News

Many cancer patients suffer from a loss of body mass known as cachexia. A new study shows that the hormone testosterone is effective at combatting cachexia in cancer patients and improving quality of life.

READ MORE

Three-Cell Ignition Required

News

New research shows that NK-cell recruitment and activation requires a rather carefully choreographed interaction of three cell types in the headquarters of the slower adaptive immune-activation: the lymph node.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy